DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

S Maier; I Nimmrich; T Koenig; S Eppenberger-Castori; I Bohlmann; A Paradiso; F Spyratos; C Thomssen; V Mueller; J Naehrig; F Schittulli; R Kates; R Lesche; I Schwope; A Kluth; A Marx; John Martens; John Foekens; M Schmitt; N Harbeck

doi:10.1016/j.ejca.2007.04.025

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

S Maier
, I Nimmrich
, T Koenig
, S Eppenberger-Castori
, I Bohlmann
, A Paradiso
, F Spyratos
, C Thomssen
, V Mueller
, J Naehrig
, F Schittulli
, R Kates
, R Lesche
, I Schwope
, A Kluth
, A Marx
, John Martens
, John Foekens
, M Schmitt
, N Harbeck

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

105 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1679-1686
Number of pages	8
Journal	European Journal of Cancer
Volume	43
Issue number	11
DOIs	https://doi.org/10.1016/j.ejca.2007.04.025
Publication status	Published - 2007

Research programs

EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2007.04.025

http://hdl.handle.net/1765/36448

Cite this

Maier, S., Nimmrich, I., Koenig, T., Eppenberger-Castori, S., Bohlmann, I., Paradiso, A., Spyratos, F., Thomssen, C., Mueller, V., Naehrig, J., Schittulli, F., Kates, R., Lesche, R., Schwope, I., Kluth, A., Marx, A., Martens, J., Foekens, J., Schmitt, M., & Harbeck, N. (2007). DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. European Journal of Cancer, 43(11), 1679-1686. https://doi.org/10.1016/j.ejca.2007.04.025

Maier, S ; Nimmrich, I ; Koenig, T et al. / DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. In: European Journal of Cancer. 2007 ; Vol. 43, No. 11. pp. 1679-1686.

@article{e5d77b939cc743df8a4a170ca062735d,

title = "DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group",

author = "S Maier and I Nimmrich and T Koenig and S Eppenberger-Castori and I Bohlmann and A Paradiso and F Spyratos and C Thomssen and V Mueller and J Naehrig and F Schittulli and R Kates and R Lesche and I Schwope and A Kluth and A Marx and John Martens and John Foekens and M Schmitt and N Harbeck",

year = "2007",

doi = "10.1016/j.ejca.2007.04.025",

language = "Undefined/Unknown",

volume = "43",

pages = "1679--1686",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "11",

}

Maier, S, Nimmrich, I, Koenig, T, Eppenberger-Castori, S, Bohlmann, I, Paradiso, A, Spyratos, F, Thomssen, C, Mueller, V, Naehrig, J, Schittulli, F, Kates, R, Lesche, R, Schwope, I, Kluth, A, Marx, A, Martens, J, Foekens, J, Schmitt, M & Harbeck, N 2007, 'DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group', European Journal of Cancer, vol. 43, no. 11, pp. 1679-1686. https://doi.org/10.1016/j.ejca.2007.04.025

DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. / Maier, S; Nimmrich, I; Koenig, T et al.
In: European Journal of Cancer, Vol. 43, No. 11, 2007, p. 1679-1686.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

AU - Maier, S

AU - Nimmrich, I

AU - Koenig, T

AU - Eppenberger-Castori, S

AU - Bohlmann, I

AU - Paradiso, A

AU - Spyratos, F

AU - Thomssen, C

AU - Mueller, V

AU - Naehrig, J

AU - Schittulli, F

AU - Kates, R

AU - Lesche, R

AU - Schwope, I

AU - Kluth, A

AU - Marx, A

AU - Martens, John

AU - Foekens, John

AU - Schmitt, M

AU - Harbeck, N

PY - 2007

Y1 - 2007

U2 - 10.1016/j.ejca.2007.04.025

DO - 10.1016/j.ejca.2007.04.025

M3 - Article

SN - 0959-8049

VL - 43

SP - 1679

EP - 1686

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 11

ER -

Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A et al. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. European Journal of Cancer. 2007;43(11):1679-1686. doi: 10.1016/j.ejca.2007.04.025